Terms: = Gastric cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
692 results:
1. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
2. Nanoparticles for Augmenting Therapeutic Potential and Alleviating the Effect of Di(2-ethylhexyl) Phthalate on gastric cancer.
Huang HL; Chen KW; Liao HW; Wang LY; Peng SL; Lai CH; Lin YH
ACS Appl Mater Interfaces; 2024 Apr; 16(15):18285-18299. PubMed ID: 38574184
[TBL] [Abstract] [Full Text] [Related]
3. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mtor signaling pathway.
Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
[TBL] [Abstract] [Full Text] [Related]
4. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mtor signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
5. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mtor-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
6. Pectolinarigenin regulates the tumor-associated proteins in AGS-xenograft BALB/c nude mice.
Lee HJ; Kwon YS; Lee JH; Moon YG; Choi J; Hyun M; Tak TK; Kim JH; Heo JD
Mol Biol Rep; 2024 Feb; 51(1):305. PubMed ID: 38361124
[TBL] [Abstract] [Full Text] [Related]
7. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract] [Full Text] [Related]
8. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mtor pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
9. Targeting PI3K/AKT/mtor and MAPK Signaling Pathways in gastric cancer.
Morgos DT; Stefani C; Miricescu D; Greabu M; Stanciu S; Nica S; Stanescu-Spinu II; Balan DG; Balcangiu-Stroescu AE; Coculescu EC; Georgescu DE; Nica RI
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339127
[TBL] [Abstract] [Full Text] [Related]
10. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mtor Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract] [Full Text] [Related]
11.
Navaneethan RD; N C J PL; Ramaiah M; Ravindran R; T AK; Chinnathambi A; Ali Alharbi S; Sivagnanam A; Mohemedibrahim PKM
Nanotechnology; 2024 Feb; 35(19):. PubMed ID: 38320329
[TBL] [Abstract] [Full Text] [Related]
12. Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mtor signaling pathway.
Yu JR; Liu YY; Gao YY; Qian LH; Qiu JL; Wang PP; Zhang GJ
J Ethnopharmacol; 2024 Apr; 324():117791. PubMed ID: 38301987
[TBL] [Abstract] [Full Text] [Related]
13. HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
Wu QN; Qi J; Liu ZK; Luo XJ; Yu K; Lu YX; Wang Y; Jin Y; Liu J; Huang LY; Zeng ZL; Zheng Y; Xu RH; Liu ZX
Cancer Lett; 2024 Mar; 584():216643. PubMed ID: 38246220
[TBL] [Abstract] [Full Text] [Related]
14. Chrysophanol induces apoptosis and ferroptosis of gastric cancer cells by targeted regulation of mtor.
Xi S; Ding W; Weng D; Zeng Y; Gao K; Wu Q; Huang G; Li Y; Yue H
Chem Biol Drug Des; 2024 Jan; 103(1):e14417. PubMed ID: 38230790
[TBL] [Abstract] [Full Text] [Related]
15. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/AKT/mtor signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract] [Full Text] [Related]
16. Roles of Rictor alterations in gastrointestinal tumors (Review).
Cao R; Guo S; Min L; Li P
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186315
[TBL] [Abstract] [Full Text] [Related]
17. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract] [Full Text] [Related]
18. [Preliminary Investigation of the Molecular Mechanism of Empagliflozin Suppressing gastric cancer Through Mammalian Target of Rapamycin].
Rao H; Cheng W; Yu J; An X; Deng H; Zhang Z; Wu F; Ji F; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1146-1153. PubMed ID: 38162062
[TBL] [Abstract] [Full Text] [Related]
19. Dual PI3K/mtor inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract] [Full Text] [Related]
20. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
[Next]
